1.TREATMENT OF MAJORLIN`S ULCER: THE ROLE OF COMBINATION CHEMOTHERAPY.
Journal of the Korean Society of Plastic and Reconstructive Surgeons 1997;24(4):761-765
No abstract available.
Drug Therapy, Combination*
;
Ulcer*
2.Combination chemotherapy for the treatment of multiple myeloma.
Hyo Jin KIM ; Chang In SEO ; Keun Chil PARK ; Heung Tae KIM ; Dae Seog HEO ; Yung Hue BANG ; Seonyang PARK ; Byoung Kook KIM ; Noe Kyeong KIM
Journal of the Korean Cancer Association 1992;24(4):577-585
No abstract available.
Drug Therapy, Combination*
;
Multiple Myeloma*
3.5-fluorouracil, epirubicin, cisplatin(FEP) and 5-fluorouracil, cisplatin(FP) combination chemotherapy for advanced pancreatic carcinoma.
Ki Hyeong LEE ; Won Ki KANG ; Chang In SUH ; Young Suk PARK ; Heung Tae KIM ; Yoon Koo KANG ; Hyo Jin KIM ; Dae Seog HEO ; Yung Jue BANG ; Yong Bum YOON ; Noe Kyeong KIM ; Yong Hyun PARK
Journal of the Korean Cancer Association 1991;23(2):315-322
No abstract available.
Drug Therapy, Combination*
;
Epirubicin*
;
Fluorouracil*
4.Mono- and Combination Chemotherapy for Metastatic Breast Cancer: An Increamental Step Forward.
Journal of Korean Breast Cancer Society 2003;6(3):137-140
No abstract available.
Breast Neoplasms*
;
Breast*
;
Drug Therapy, Combination*
5.A randomized comparison of antiemetic effect of ondansetron versus MDL(metoclopramide/dexamethasone/lorazepam) in patients receiving cisplatin-based combination chemotherapy.
Young Hyuck IM ; Young Suk PARK ; Joungsoon JANG ; Jae Yong LEE ; Sungsoo YOON ; Dae Seog HEO ; Yung Jue BANG ; Noe Kyeong KIM
Journal of the Korean Cancer Association 1992;24(3):378-389
No abstract available.
Antiemetics*
;
Drug Therapy, Combination*
;
Humans
;
Ondansetron*
6.The Relationship between MDR1 Polymorphisms and the Response to Etoposide/Cisplatin Combination Chemotherapy in Small Cell Lung Cancer.
Ji Woong SOHN ; Shin Yup LEE ; Su Jung LEE ; Hyo Sung JEON ; Jae Hee LEE ; Jae Hyung PARK ; Eun Jin KIM ; Seung Ick CHA ; Chang Ho KIM ; Young Mo KANG ; Jae Tae LEE ; Tae Hoon JUNG ; Jae Yong PARK
Tuberculosis and Respiratory Diseases 2005;58(2):135-141
No abstract available.
Drug Therapy, Combination*
;
Small Cell Lung Carcinoma*
7.Treatment with augmented TAD combination chemotherapy and consolidation in patient with acute myelogenous leukemia.
Do Jin KIM ; Jung Sil WHANG ; Jong Ho WON ; Dae Sik HONG ; Hee Sook PARK ; Won Bae KIM
Journal of the Korean Cancer Association 1991;23(4):798-805
No abstract available.
Drug Therapy, Combination*
;
Humans
;
Leukemia, Myeloid, Acute*
8.Treatment of intermediate-grade non-Hodgkin's lymphoma with CAMP-MOB combination chemotherapy.
Chang In SUH ; Heung Tae KIM ; Dong Bok SHIN ; Jae Hoon LEE ; Dae Seog HEO ; Yung Jue BANG ; Seonyang PARK ; Byoung Kook KIM ; Noe Kyeong KIM
Journal of the Korean Cancer Association 1992;24(1):102-108
No abstract available.
Drug Therapy, Combination*
;
Lymphoma, Non-Hodgkin*
9.A Case of Intractable Hiccup Controlled by Combination Drug Therapy with Levosulpiride, Omeprazole and Baclofen.
Kyoung Rok KIM ; Mi Ra KIM ; Choong Kun HA ; Seong Hye CHOI
Journal of the Korean Neurological Association 2003;21(3):318-319
No abstract available.
Baclofen*
;
Drug Therapy, Combination*
;
Hiccup*
;
Omeprazole*
10.COP-BLAM III(cyclophosphamide/vincristine/prednisolone/bleomycin/ adriamycin/procarbazine) combination chemotherapy for the treatment of intermediate and high grade non-Hodgkin's lymphoma.
Keong Hae JUNG ; Young Iee PARK ; Kee Heung LEE ; Young Suk PARK ; Chang In SUH ; Won Ki KANG ; Heung Tae KIM ; Cheol Won SUH ; Dae Seog HEO ; Yung Jue BANG ; Seonyang PARK ; Noe Kyeong KIM
Journal of the Korean Cancer Association 1992;24(4):586-595
No abstract available.
Drug Therapy, Combination*
;
Lymphoma, Non-Hodgkin*
Result Analysis
Print
Save
E-mail